Intermittent preventive treatment with sulphadoxine-pyrimethamine but not dihydroartemisinin-piperaquine modulates the relationship between inflammatory markers and adverse pregnancy outcomes in malawi

HIGHLIGHTS

• What: CRP and AGP levels along with clinical data that support the findings this study have been uploaded to the WorldWide Antimalarial Research Network (WWARN) in the Infectious Diseases Data Observatory (IDDO). This study showed strong associations between inflammation and adverse outcomes in participants receiving a single dose of SP and chloroquine but not in those receiving multiple doses of SP+AZ. The authors investigated whether AGP and CRP are markers of adverse birth outcomes in a subset of the IMPROVE cohort, pregnant Malawian women.
• Who: Kaylene Cheng et al. from the Training Center, University . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.